Showing 11-20 of 23 grants

Title Institution Researcher Program Duration Total Award Amount
Innovating Methods for AssessinG INsulin Action in Type ONe diabetes (IMAGINATiON) Regents of the University of Colorado Kristen Nadeau Improving Lives 01-December-2021 to 30-November-2025 $445,816.29
Validation of Enzyme-linked immunosorbent assay (ELISA) to detect insulin autoantibodies Regents of the University of Colorado Liping Yu Cures 01-June-2025 to 31-May-2027 $453,852.00
Antigenic Targets of CD4 T cells across the stages of type 1 diabetes Regents of the University of Colorado Maki Nakayama Cures 01-August-2022 to 31-July-2026 $750,000.00
Autoimmunity Screening for Kids (ASK) Regents of the University of Colorado Marian Rewers Cures 01-November-2024 to 31-October-2027 $3,074,807.75
IL-37-EXPRESSING TREG CELLS TO IMPROVE T1D THERAPEUTIC STRATEGY Regents of the University of Colorado Mayumi Fujita Cures 01-March-2023 to 28-February-2026 $750,000.00
Clinical and Economic Optimization Platform for Type 1 Diabetes Screening Regents of the University of Colorado R. Brett McQueen Cures 01-September-2022 to 31-August-2024 $483,523.62
Improving the Uptake and Applicability of the Clinical and Economic Optimization Platform for Type 1 Diabetes Screening Regents of the University of Colorado R. Brett McQueen Cures 01-September-2024 to 31-August-2026 $451,890.07
Defining human T cell-myeloid cell interactions in the islets Regents of the University of Colorado Rachel Friedman Cures 01-March-2023 to 28-February-2026 $110,000.00
Targeting sub-micron ultrasound contrast agents to the immune-infiltrated islet microenvironment in Type1 diabetes Regents of the University of Colorado Richard Benninger Cures 01-July-2024 to 30-June-2027 $900,000.00
Testing the role of the PI3K-AKT-FOXO1-CXCR4 pathway in the bone marrow selection of anti-insulin B cells in T1D Regents of the University of Colorado Roberta Pelanda Cures 01-November-2023 to 31-October-2026 $826,284.00